Keyphrases
End Organ
100%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
100%
Endothelial Activation
100%
Organ Toxicity
100%
Endothelial Injury
100%
Hematopoietic Stem Cell Transplantation
66%
High Risk
33%
Life-threatening Complications
33%
Inflammation
33%
Translational Research
33%
Vascular Endothelial Cells
33%
Therapeutic Potential
33%
Curative Treatment
33%
Treatment Options
33%
Clinical Manifestations
33%
Neoplastic Disease
33%
Supportive Care
33%
Critical Care Medicine
33%
Hematological Diseases
33%
Thrombotic Microangiopathy
33%
Endothelial Cell Activation
33%
Endothelial Cell Injury
33%
Transplant Immunology
33%
Medicine and Dentistry
Injury
100%
Organ Toxicity
100%
Allogeneic Hematopoietic Stem Cell Transplantation
100%
Hematopoietic Stem Cell Transplantation
66%
Disease
33%
Neoplasm
33%
Translational Research
33%
Transplantation
33%
Supportive Care
33%
Cell Damage
33%
Vascular Endothelial Cell
33%
Microangiopathy
33%
Intensive Care Medicine
33%
Sulfhemoglobinemia
33%
Cell Activation
33%
Transplantation Immunology
33%
Immunology and Microbiology
Allogeneic Hematopoietic Stem Cell Transplantation
100%
Hematopoietic Stem Cell Transplantation
66%
Transplant Procedure
33%
Cell Activation
33%
Cell Damage
33%
Vascular Endothelial Cell
33%
Transplantation Immunology
33%